benzimidazol-2-one has been researched along with 1-ethyl-2-benzimidazolinone in 1 studies
| Studies (benzimidazol-2-one) | Trials (benzimidazol-2-one) | Recent Studies (post-2010) (benzimidazol-2-one) | Studies (1-ethyl-2-benzimidazolinone) | Trials (1-ethyl-2-benzimidazolinone) | Recent Studies (post-2010) (1-ethyl-2-benzimidazolinone) |
|---|---|---|---|---|---|
| 18 | 0 | 9 | 126 | 0 | 37 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahring, PK; Christophersen, P; Hansen, RS; Jørgensen, TD; Kjaer, K; Olesen, SP; Skaaning-Jensen, B; Strøbaek, D; Teuber, L | 1 |
1 other study(ies) available for benzimidazol-2-one and 1-ethyl-2-benzimidazolinone
| Article | Year |
|---|---|
Activation of human IK and SK Ca2+ -activated K+ channels by NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime).
Topics: Benzimidazoles; Calcium Channel Agonists; Cell Line; Dose-Response Relationship, Drug; Humans; Indoles; Intermediate-Conductance Calcium-Activated Potassium Channels; Kinetics; Oximes; Patch-Clamp Techniques; Potassium Channels, Calcium-Activated; Small-Conductance Calcium-Activated Potassium Channels | 2004 |